Professor Paul Hertzog leads a multidisciplinary research team investigating the Regulation of Innate immune and Interferon Signalling  at the Centre for Innate Immunity & Infectious Diseases,  Hudson Institute. The program includes: structure-function of type I IFNs and receptors. IFN responses are examined by a systems biology approach. They discovered and are characterising the function of the unique type I IFN epsilon, a constitutive, epithelial regulator of mucosal immunity against infection and cancer in the female reproductive, gastrointestinal and respiratory tracts.  His group made seminal discoveries about IFN’s mechanism of action, published in Nature, Science, Cell. They  use their molecular insights for clinical impact.  He was awarded the prestigious Milstein Award for Research Excellence by the International Cytokine and Interferon Society. He is a keen supporter of open, collaborative science, proud to have co-founded the VIIN network and the Lorne I&I conference which he co-convened from 2010 until 2021.